Responses
Asthma
Original article
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
Compose a Response to This Article
Other responses
No responses have been published for this article.